You are here

Eli Lilly

Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says

Reuters

Thu, 02/22/24 - 11:14 pm

Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4

Fierce Pharma

Thu, 02/22/24 - 11:12 pm

Eli Lilly Has More Than an Ozempic Competitor -- Much More

Motley Fool

Wed, 02/21/24 - 11:14 am

Alzheimer's disease

Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023

BioSpace

Tue, 02/20/24 - 05:55 pm

After migraine accord with Eli Lilly, Organon CEO scouts more deals to bolster growth

Fierce Pharma

Fri, 02/16/24 - 11:45 am

Britain sees launch of Lilly's weight-loss drug Mounjaro

Reuters

Wed, 02/14/24 - 11:31 am

3 questions hanging over the Novo-Catalent deal

Pharma Voice

Wed, 02/14/24 - 10:55 am

drug manufacturing

Eli Lilly partner BioAge raises $170 mln for obesity treatment

Reuters

Tue, 02/13/24 - 11:24 am

COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings

BioSpace

Sun, 02/11/24 - 03:50 pm

Bristol Myers Squibb

New weight-loss drugs linked to lower risk of depression: study

Axios

Fri, 02/9/24 - 11:12 am

Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Motley Fool

Thu, 02/8/24 - 10:01 pm

Eli Lilly’s Verzenio fails prostate cancer test as possible Novartis showdown nears

Fierce Pharma

Wed, 02/7/24 - 11:26 am

prostate cancer

Eli Lilly settles Minnesota lawsuit over insulin pricing

Reuters

Wed, 02/7/24 - 11:19 am

Lilly expects strong 2024 profit on rising weight-loss drug demand

Reuters

Tue, 02/6/24 - 10:16 am

Eli Lilly axes next-generation, resistance-busting RET inhibitor

Fierce Biotech

Tue, 02/6/24 - 10:14 am

non-small cell lung cancer

Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains

Fierce Pharma

Tue, 02/6/24 - 09:33 am

Could Novo, Lilly become first trillion-dollar healthcare companies?

Pharma Voice

Mon, 02/5/24 - 10:30 am

FDA website shows limited availability of some doses of Lilly's Mounjaro

Reuters

Mon, 02/5/24 - 10:12 am

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Pharmaceutical Business Review

Mon, 02/5/24 - 10:11 am

Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?

Motley Fool

Fri, 02/2/24 - 11:50 am

Pages